3D Cell Culture Market Size, Share, Industry Report [2032]
3D Cell Culture Market Size, Share, Industry Report [2032]
Segments - 3D Cell Culture Market by Technology (Scaffold-based, Scaffold-free, Bioreactors, Microfluidics, and Bioprinting), Products (Hydrogel / Extracellular Matrix (ECM), 3D Bioreactor, 3D Petri Dish, Hanging Drop Plate, Microfluidic System, Micropatterned Surface, Microcarrier, Solid Scaffold, and Suspension System), Application (Cancer Research, Drug Discovery, Toxicology, Stem Cell Research, Tissue Engineering, and Regenerative Medicine), End-user (Biotechnology & Pharmaceutical Industries, Research Laboratories & Institutes, Hospitals & Diagnostic Centers, and Others), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2024 – 2032
Upcoming
| Report ID :HC-6538
| 4.8 Rating
| 90 Reviews
| 293 Pages
| Format :
Report Description
3D Cell Culture Market Outlook 2032
The global 3D cell culture market size was USD 1.7 Billion in 2023 and is likely to reach USD 6.6 Billion by 2032, expanding at a CAGR of 16.3% during 2024–2032. The market growth is attributed to the growing demand for personalized medicines.
3D cell culture refers to the use of three-dimensional (3D) structures to grow and maintain cells in vitro, as opposed to traditional two-dimensional (2D) cell culture methods. In 3D cell culture, cells are grown in a three-dimensional matrix or scaffold that mimics the natural environment of the cells in the body.
In traditional 2D cell culture, cells are grown on a flat surface, such as a petri dish or a microscope slide. While this method has been widely used for many years, it has several limitations. For example, cells grown in 2D do not accurately reflect the natural environment of the cells in the body, where cells are surrounded by other cells and extracellular matrix.
Impact of Artificial Intelligence (AI) in 3D Cell Culture Market
Improvisation in the data analytics and automated image analysis because of the AI-powered 3D cell culture experiments is boosting the global market. AI algorithms analyzes large amounts of data generated from 3D cell culture experiments, enabling researchers to identify patterns and trends that would be difficult to detect manually. Moreover, AI-powered image analysis tools automatically analyze images of 3D cell cultures, allowing researchers to quickly and accurately quantify cell morphology, density, and other parameters.
3D Cell Culture Market Dynamics
Major Drivers
Growing demand for personalized medicines is driving the market. Increasing focus on personalized medicine has led to a growing demand for 3D cell culture technology, which enables the creation of patient-specific cell models for treatment and diagnosis. Furthermore, the increasing adoption in pharmaceuticals and biotech companies is boosting the market.
Existing Restraints
High cost of equipment and reagents is hindering the global market. The cost of 3D cell culture equipment and reagents can be prohibitively expensive, making it difficult for some researchers and companies to adopt this technology. Moreover, the complexity of 3D cell culture is expected to constrain the global market.
Emerging Opportunities
Increasing focus on personalized medicines is driving the demand for 3D cell culture technology, enabling the creation of patient-specific cell models for treatment and diagnosis. Moreover, the growth of regenerative medicine is driving the demand for 3D cell culture technology, which enables the development of new treatments and therapies for diseases such as Parkinson's and Alzheimer's.
Scope of the 3D Cell Culture Market Report
The market report includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
3D Cell Culture Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2023 |
|
Historic Data |
2017–2022 |
|
Forecast Period |
2024–2032 |
|
Segmentation |
Technology (Scaffold-based, Scaffold-free, Bioreactors, Microfluidics, and Bioprinting), Products (Hydrogel / Extracellular Matrix (ECM), 3D Bioreactor, 3D Petri Dish, Hanging Drop Plate, Microfluidic System, Micropatterned Surface, Microcarrier, Solid Scaffold, and Suspension System), Application (Cancer Research, Drug Discovery, Toxicology, Stem Cell Research, Tissue Engineering, and Regenerative Medicine), End-user (Biotechnology & Pharmaceutical Industries, Research Laboratories & Institutes, Hospitals & Diagnostic Centers, and Others) |
|
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast |
|
Key Players Covered in the Report |
CN Bio Innovations Ltd; Eppendorf AG; GE Healthcare; Lena Biosciences; Lonza; Merck KGaA; PromoCell GmbH; Sartorius AG; and Thermo Fisher Scientific Inc. |
Market Segment Insights
Regional Analysis
In terms of region, the global 3D cell culture market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America dominates the global market in 2023 owing to the strong presence of biotech and pharmaceutical companies. North America is home to many world-renowned research institutions, universities, and hospitals, which are driving the adoption of 3D cell culture technology for R&D. Moreover, the high demand for personalized treatment is driving the regional market.
The market in Europe is projected to grow at a significant pace in the years to come owing to the strong biotech and pharmaceutical industry. Europe has a strong focus on regenerative medicine, and 3D cell culture technology is being used to develop new treatments and therapies for diseases such as Parkinson's and Alzheimer's. This therefore is boosting the regional market significantly.
Segment Analysis
Technology Segment Analysis
Based on technology, the 3D cell culture market is divided into scaffold-based, scaffold-free, bioreactors, microfluidics, and bioprinting. The scaffold-free segment held the largest share in the global market in 2023 owing to its numerous advantages. The scaffold-free segment reduces the complexity and cost with improving cell viability and proliferation. Moreover, growing demand of scaffold-free technologies in regenerative and tissue engineering is boosting the segment.
The bioreactors segment is anticipated to expand at a substantial CAGR during the forecast period due to the advancement in technology. Recent advancements in bioreactor design and control systems have improved their performance, scalability, and flexibility, making them attractive to researchers and clinicians. Moreover, the wide application of bioreactors in cell therapy and cancer research is expected to propel the segment during the forecast period. Additionally, increasing number of product launch is expected to boost the segment during the projection period. For instance,
-
In May 2021, Beckman Coulter Life Sciences introduced its cutting-edge BioLector XT Microbioreactor in Germany, marking a significant milestone. This innovative device empowers researchers to monitor cultivation parameters, conduct high-throughput strain screenings, and optimize feeding strategies, revolutionizing the way they cultivate and analyze microorganisms.
Products Segment Analysis
On the basis of products, the global market is segregated into hydrogel/extracellular matrix (ECM), 3D bioreactor, 3D petri dish, hanging drop plate, microfluidic system, micropatterned surface, microcarrier, solid scaffold, and suspension system. The hydrogel/extracellular Matrix (ECM) segment is anticipated to register a considerable CAGR during the forecast period owing to its versatility. Hydrogels and ECMs are designed to mimic the properties of native tissues, making them suitable for a wide range of cell types and tissues, thus driving the segment.
The 3D bioreactor segment is projected to register a robust growth during the assessment years due to its cost-effectiveness. Furthermore, the flexibility of 3D bioreactors to mimic various physiological environments is driving the segment significantly. The demand for 3D bioreactors is increasing due to the growing need for large-scale, controlled environments for cell culture and tissue engineering applications.
Application Segment Analysis
Basis on application, the 3D cell culture market is segmented into cancer research, drug discovery, toxicology, stem cell research, tissue engineering, and regenerative medicine. The cancer research segment registers a robust growth rate in 2023 owing to the growing need for personalized medicines. Additionally, increasing funding for cancer research and the development of new treatments is expected to propel the segment during the projection period. For instance,
-
In 2020, World Health Organization (WHO), cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths, propelling the demand for increasing R&D activities.
The drug discovery segment is expected to expand at a significant growth rate over the projection period owing to the increasing demand for targeted medications. Increasing demand for personalized medicine and targeted therapies has led to a growing need for accurate and relevant in vitro models for drug discovery.
End-user Segment Analysis
Based on end-user, the 3D cell culture market is divided into biotechnology & pharmaceutical industries, research laboratories & institutes, hospitals & diagnostic centers, and others. The research laboratories & institutes segment held the largest share in the global market in 2023 owing to the increasing R&D activities. 3D cell culture technology can be applied to a wide range of research areas, including cancer research, stem cell research, and regenerative medicine, driving the segment.
The hospitals & diagnostic centers segment is anticipated to expand at a substantial CAGR during the forecast period due to the advanced cancer treatment. Cancer is a leading cause of deaths globally. This is leading to the increasing demand for an effective drug to treat it. 3D cell culture technology is being used to develop accurate and effective cancer models for R&D. This has increased the demand for 3D cell culture products and services in hospitals and diagnostic centers.
Segments
The 3D cell culture market has been segmented on the basis of
Technology
- Scaffold-based
- Scaffold-free
- Bioreactors
- Microfluidics
- Bioprinting
Products
- Hydrogel/Extracellular Matrix (ECM)
- 3D Bioreactor
- 3D Petri Dish
- Hanging Drop Plate
- Microfluidic System
- Micropatterned Surface
- Microcarrier
- Solid Scaffold
- Suspension System
Application
- Cancer Research
- Drug Discovery
- Toxicology
- Stem Cell Research
- Tissue Engineering
- Regenerative Medicine
End-user
- Biotechnology & Pharmaceutical Industries
- Research Laboratories & Institutes
- Hospitals & Diagnostic Centers
- Others
Region
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- CN Bio Innovations Ltd
- Eppendorf AG
- GE Healthcare
- Lena Biosciences
- Lonza
- Merck KGaA
- PromoCell GmbH
- Sartorius AG
- Thermo Fisher Scientific Inc.
Competitive Landscape
Key players competing in the global 3D cell culture market are CN Bio Innovations Ltd; Eppendorf AG; GE Healthcare; Lena Biosciences; Lonza; Merck KGaA; PromoCell GmbH; Sartorius AG; and Thermo Fisher Scientific Inc.
-
In August 2021, Amerigo Scientific has further expanded its cell culture offerings with the introduction of a cutting-edge 3D Cell Culture system, designed to support a wide range of scientific applications. This innovative technology enables researchers to explore various fields, including drug discovery, medicine, nanomaterial evaluation, and fundamental life sciences.
-
In January 2021, Jellagen Limited, a biotech company specializing in the production of high-value Collagen Type 0 derived from jellyfish, is proud to introduce its latest innovation, JellaGel Hydrogel, a revolutionary 3D hydrogel. This groundbreaking product offers researchers a unique opportunity to transform their work, providing a non-mammalian, natural, biochemically simple, consistent, and easy-to-use hydrogel that can revolutionize their research.
Table Of Content
1. Executive Summary2. Assumptions and Acronyms Used
3. Research Methodology
4. 3D Cell Culture Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. 3D Cell Culture Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. 3D Cell Culture Market - Supply Chain
4.5. Global 3D Cell Culture Market Forecast
4.5.1. 3D Cell Culture Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. 3D Cell Culture Market Size (000’ Units) and Y-o-Y Growth
4.5.3. 3D Cell Culture Market Absolute $ Opportunity
5. Global 3D Cell Culture Market Analysis and Forecast by Applications
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Applications
5.2.2. Y-o-Y Growth Projections by Applications
5.3. 3D Cell Culture Market Size and Volume Forecast by Applications
5.3.1. Cancer Research
5.3.2. Drug Discovery
5.3.3. Toxicology
5.3.4. Stem Cell Research
5.3.5. Tissue Engineering
5.3.6. Regenerative Medicine
5.4. Absolute $ Opportunity Assessment by Applications
5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global 3D Cell Culture Market Analysis and Forecast by End Users
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by End Users
6.2.2. Y-o-Y Growth Projections by End Users
6.3. 3D Cell Culture Market Size and Volume Forecast by End Users
6.3.1. Biotechnology & Pharmaceutical Industries
6.3.2. Research Laboratories & Institutes
6.3.3. Hospitals & Diagnostic Centers
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by End Users
6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global 3D Cell Culture Market Analysis and Forecast by Region
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Region
7.2.2. Y-o-Y Growth Projections by Region
7.3. 3D Cell Culture Market Size and Volume Forecast by Region
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa (MEA)
7.4. Absolute $ Opportunity Assessment by Region
7.5. Market Attractiveness/Growth Potential Analysis by Region
7.6. Global 3D Cell Culture Demand Share Forecast, 2019-2026
8. North America 3D Cell Culture Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.2. North America 3D Cell Culture Market Size and Volume Forecast by Country
8.2.1. U.S.
8.2.2. Canada
8.3. Absolute $ Opportunity Assessment by Country
8.4. North America 3D Cell Culture Market Size and Volume Forecast by Applications
8.4.1. Cancer Research
8.4.2. Drug Discovery
8.4.3. Toxicology
8.4.4. Stem Cell Research
8.4.5. Tissue Engineering
8.4.6. Regenerative Medicine
8.5. Basis Point Share (BPS) Analysis by Applications
8.6. Y-o-Y Growth Projections by Applications
8.7. North America 3D Cell Culture Market Size and Volume Forecast by End Users
8.7.1. Biotechnology & Pharmaceutical Industries
8.7.2. Research Laboratories & Institutes
8.7.3. Hospitals & Diagnostic Centers
8.7.4. Others
8.8. Basis Point Share (BPS) Analysis by End Users
8.9. Y-o-Y Growth Projections by End Users
8.10. Market Attractiveness/Growth Potential Analysis
8.10.1. By Country
8.10.2. By Product Type
8.10.3. By Application
8.11. North America 3D Cell Culture Demand Share Forecast, 2019-2026
9. Latin America 3D Cell Culture Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Latin America Average Pricing Analysis
9.2. Latin America 3D Cell Culture Market Size and Volume Forecast by Country
9.2.1. Brazil
9.2.2. Mexico
9.2.3. Rest of Latin America
9.3. Absolute $ Opportunity Assessment by Country
9.4. Latin America 3D Cell Culture Market Size and Volume Forecast by Applications
9.4.1. Cancer Research
9.4.2. Drug Discovery
9.4.3. Toxicology
9.4.4. Stem Cell Research
9.4.5. Tissue Engineering
9.4.6. Regenerative Medicine
9.5. Basis Point Share (BPS) Analysis by Applications
9.6. Y-o-Y Growth Projections by Applications
9.7. Latin America 3D Cell Culture Market Size and Volume Forecast by End Users
9.7.1. Biotechnology & Pharmaceutical Industries
9.7.2. Research Laboratories & Institutes
9.7.3. Hospitals & Diagnostic Centers
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by End Users
9.9. Y-o-Y Growth Projections by End Users
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.11. Latin America 3D Cell Culture Demand Share Forecast, 2019-2026
10. Europe 3D Cell Culture Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Europe Average Pricing Analysis
10.2. Europe 3D Cell Culture Market Size and Volume Forecast by Country
10.2.1. Germany
10.2.2. France
10.2.3. Italy
10.2.4. U.K.
10.2.5. Spain
10.2.6. Russia
10.2.7. Rest of Europe
10.3. Absolute $ Opportunity Assessment by Country
10.4. Europe 3D Cell Culture Market Size and Volume Forecast by Applications
10.4.1. Cancer Research
10.4.2. Drug Discovery
10.4.3. Toxicology
10.4.4. Stem Cell Research
10.4.5. Tissue Engineering
10.4.6. Regenerative Medicine
10.5. Basis Point Share (BPS) Analysis by Applications
10.6. Y-o-Y Growth Projections by Applications
10.7. Europe 3D Cell Culture Market Size and Volume Forecast by End Users
10.7.1. Biotechnology & Pharmaceutical Industries
10.7.2. Research Laboratories & Institutes
10.7.3. Hospitals & Diagnostic Centers
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by End Users
10.9. Y-o-Y Growth Projections by End Users
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.11. Europe 3D Cell Culture Demand Share Forecast, 2019-2026
11. Asia Pacific 3D Cell Culture Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Asia Pacific Average Pricing Analysis
11.2. Asia Pacific 3D Cell Culture Market Size and Volume Forecast by Country
11.2.1. China
11.2.2. Japan
11.2.3. South Korea
11.2.4. India
11.2.5. Australia
11.2.6. Rest of Asia Pacific (APAC)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Asia Pacific 3D Cell Culture Market Size and Volume Forecast by Applications
11.4.1. Cancer Research
11.4.2. Drug Discovery
11.4.3. Toxicology
11.4.4. Stem Cell Research
11.4.5. Tissue Engineering
11.4.6. Regenerative Medicine
11.5. Basis Point Share (BPS) Analysis by Applications
11.6. Y-o-Y Growth Projections by Applications
11.7. Asia Pacific 3D Cell Culture Market Size and Volume Forecast by End Users
11.7.1. Biotechnology & Pharmaceutical Industries
11.7.2. Research Laboratories & Institutes
11.7.3. Hospitals & Diagnostic Centers
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by End Users
11.9. Y-o-Y Growth Projections by End Users
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.11. Asia Pacific 3D Cell Culture Demand Share Forecast, 2019-2026
12. Middle East & Africa 3D Cell Culture Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Middle East & Africa Average Pricing Analysis
12.2. Middle East & Africa 3D Cell Culture Market Size and Volume Forecast by Country
12.2.1. Saudi Arabia
12.2.2. South Africa
12.2.3. UAE
12.2.4. Rest of Middle East & Africa (MEA)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Middle East & Africa 3D Cell Culture Market Size and Volume Forecast by Applications
12.4.1. Cancer Research
12.4.2. Drug Discovery
12.4.3. Toxicology
12.4.4. Stem Cell Research
12.4.5. Tissue Engineering
12.4.6. Regenerative Medicine
12.5. Basis Point Share (BPS) Analysis by Applications
12.6. Y-o-Y Growth Projections by Applications
12.7. Middle East & Africa 3D Cell Culture Market Size and Volume Forecast by End Users
12.7.1. Biotechnology & Pharmaceutical Industries
12.7.2. Research Laboratories & Institutes
12.7.3. Hospitals & Diagnostic Centers
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by End Users
12.9. Y-o-Y Growth Projections by End Users
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.11. Middle East & Africa 3D Cell Culture Demand Share Forecast, 2019-2026
13. Competition Landscape
13.1. Global 3D Cell Culture Market: Market Share Analysis
13.2. 3D Cell Culture Distributors and Customers
13.3. 3D Cell Culture Market: Competitive Dashboard
13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
13.4.1. CN Bio Innovations Ltd
13.4.2. Eppendorf AG
13.4.3. GE Healthcare
13.4.4. Lena Biosciences
13.4.5. Lonza
13.4.6. Merck KGaA
13.4.7. PromoCell GmbH
13.4.8. Sartorius AG
13.4.9. Thermo Fisher Scientific Inc.
Methodology
Related Reports
Some other reports from this category!
Our Clients
